Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 2;6(1):e70199.
doi: 10.1002/deo2.70199. eCollection 2026 Apr.

Factors Influencing Resection Time in Endoscopic Submucosal Dissection for Rectal Neuroendocrine Tumors

Affiliations

Factors Influencing Resection Time in Endoscopic Submucosal Dissection for Rectal Neuroendocrine Tumors

Shinya Nakatani et al. DEN Open. .

Abstract

Objectives: The usefulness of endoscopic submucosal dissection (ESD) for rectal neuroendocrine tumors (NETs) is well established. However, factors influencing resection time remain unclear. This study aimed to identify these factors during ESD for rectal NETs.

Methods: This retrospective study included 194 rectal NET lesions that were treated with ESD at our institution between March 2011 and July 2024. Potential factors influencing resection time-including age, sex, operator experience (non-expert endoscopist: <50 colorectal ESD cases), sodium hyaluronate use, traction device (TD) use, tumor location, lesion size, and specimen area-were analyzed using multiple regression analysis.

Results: The median resection time was 30 min (interquartile range [IQR]: 20-43 min). Non-expert endoscopists performed 53% of the procedures. The median specimen area was 302 mm2 (IQR: 233-393 mm2). Resection time was significantly longer when procedures were performed by non-experts (β = 8.66; 95% confidence interval [CI]: 4.46-12.86; p <0.001), when the tumor was located in the upper rectum (Rs) compared to the lower rectum (Rb) (β = 20.96; 95% CI: 7.82-34.1; p = 0.002), and with increasing specimen area (β = 0.04; 95% CI: 0.027-0.06; p <0.001). Conversely, TD use significantly shortened resection time (β = -5.90; 95% CI: -11.37 to -0.43; p = 0.036).

Conclusions: Traction device use during ESD for rectal NETs is associated with shorter resection time; whereas, procedures performed by non-experts, tumors located in the Rs, and larger specimen areas were associated with longer resection time.

Keywords: endoscopic submucosal dissection; neuroendocrine tumor; procedure time; rectum; traction device.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Flow diagram of patient selection for the study. ESD, endoscopic submucosal dissection; NET, neuroendocrine tumor.
FIGURE 2
FIGURE 2
Step‐by‐step endoscopic submucosal dissection (ESD) of a rectal neuroendocrine tumor using a multi‐loop traction device. (a) Endoscopic view of a 7‐mm neuroendocrine tumor in the Ra segment of the rectum. (b) Marking dots placed circumferentially around the lesion. (c) Full circumferential mucosal incision prior to dissection, followed by the application of traction using a multi‐loop traction device. (d) Dissection phase assisted by the multi‐loop traction device. (e) Post‐ESD ulcer bed observed after complete resection. (f) Resected specimen after ESD. Ra, middle rectum.

Similar articles

References

    1. Gordon J. I. and Hermiston M. L., “Differentiation and Self‐renewal in the Mouse Gastrointestinal Epithelium,” Current Opinion in Cell Biology 6 (1994): 795–803. - PubMed
    1. Yao J. C., Hassan M., Phan A., et al., “One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States,” Journal of Clinical Oncology 26 (2008): 3063–3072. - PubMed
    1. Cho M. Y., Kim J. M., Sohn J. H., et al., “Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP‐NETs) in Korea 2000–2009: Multicenter Study,” Cancer research and treatment: official journal of Korean Cancer Association 44 (2012): 157–165. - PMC - PubMed
    1. Tsai H. J., Wu C. C., Tsai C. R., et al., “The Epidemiology of Neuroendocrine Tumors in Taiwan: A Nationwide Cancer Registry‐based Study,” PLoS ONE 8 (2013): e62487. - PMC - PubMed
    1. Fraenkel M., Kim M., Faggiano A., et al., “Incidence of Gastroenteropancreatic Neuroendocrine Tumours: A Systematic Review of the Literature,” Endocrine‐Related Cancer 21 (2014): R153–R163. - PubMed

LinkOut - more resources